| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.862 | 47.278 | 54.985 | 55.851 | 55.375 | 61.421 | 82.560 | 93.147 |
| Total Income - EUR | - | - | 6.862 | 47.279 | 54.987 | 57.988 | 55.376 | 61.422 | 82.567 | 93.151 |
| Total Expenses - EUR | - | - | 12.857 | 21.014 | 19.947 | 26.387 | 21.988 | 26.667 | 36.502 | 35.326 |
| Gross Profit/Loss - EUR | - | - | -5.995 | 26.265 | 35.040 | 31.601 | 33.388 | 34.756 | 46.065 | 57.825 |
| Net Profit/Loss - EUR | - | - | -6.063 | 25.793 | 34.520 | 31.253 | 32.845 | 34.154 | 45.342 | 55.086 |
| Employees | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Ormenimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 128 | 0 | 0 | 0 | 944 | 1.540 | 1.150 |
| Current Assets | - | - | 6.207 | 21.954 | 41.916 | 35.033 | 34.467 | 35.102 | 49.577 | 63.260 |
| Inventories | - | - | 0 | 0 | 614 | 602 | 710 | 757 | 0 | 0 |
| Receivables | - | - | 3.292 | 17.423 | 4.373 | 6.951 | 5.021 | 30.154 | 21.124 | 39.544 |
| Cash | - | - | 2.915 | 4.532 | 36.929 | 27.480 | 28.736 | 4.191 | 28.453 | 23.715 |
| Shareholders Funds | - | - | -6.020 | 19.884 | 40.266 | 31.476 | 32.894 | 33.977 | 47.692 | 55.135 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 12.227 | 2.199 | 1.650 | 3.557 | 1.573 | 2.069 | 3.425 | 9.275 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ormenimed Srl